Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
HCWB
HCWB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
HCWB News
HCW Biologics Regains Full Rights to HCW9206 and HCW9201 Compounds
4d ago
seekingalpha
E.F. Hutton Secures $4 Million Financing for HCW Biologics
May 22 2026
Newsfilter
Biotech Sector Attracts Investor Attention Amid Innovation
May 22 2026
Globenewswire
HCW Biologics Completes Private Placement Financing
May 21 2026
Newsfilter
HCW Biologics Stock Surges 129% Amid Concerns
May 21 2026
NASDAQ.COM
Biologics Sector Rapidly Emerging as Growth Leader
May 15 2026
Newsfilter
HCW Biologics Q1 Earnings Significantly Exceed Expectations
May 14 2026
seekingalpha
HCW Biologics' HCW11-040 Prevents BPD in Clinical Studies
May 14 2026
Newsfilter
HCW Biologics Reports Progress on Anti-Tumor Drug HCW11-018b
Apr 28 2026
NASDAQ.COM
HCW Biologics Advances T-Cell Engager HCW11-018b for Pancreatic Cancer
Apr 27 2026
Newsfilter
HCW Biologics Reports Q4 Results and Nasdaq Compliance Notice
Apr 01 2026
NASDAQ.COM
HCW Biologics Reports Q4 2024 Financial Highlights
Mar 31 2026
seekingalpha
HCW Biologics Reports Q4 2025 Financial Results and Clinical Trial Updates
Mar 31 2026
Newsfilter
HCW Biologics Secures $7M License Fee from Beijing Trimmune
Mar 17 2026
NASDAQ.COM
HCW Biologics Shares Surge 56% on Positive CAR-T Therapy Results
Mar 16 2026
stocktwits
Alopecia Areata Market Poised for Significant Growth
Feb 19 2026
Newsfilter
Show More News
